FDA product code DEB: Alpha-2-Macroglobulin, Antigen, Antiserum, Control

DEB is the FDA product code for alpha-2-macroglobulin, antigen, antiserum, control. It is a Class II device, regulated under 21 CFR 866.5620 and reviewed by the Immunology panel. FDA has cleared 13 510(k) submissions under DEB, from 11 different applicants. The average 510(k) review took 66 days (median 31).

Classification

FieldValue
Device nameAlpha-2-Macroglobulin, Antigen, Antiserum, Control
Device classClass II
Regulation21 CFR 866.5620
Review panelIM — Immunology
Medical specialtyImmunology
Premarket route510(k) exempt

Compare with all 510(k) review times · Search every DEB clearance

Top DEB applicants

ApplicantClearancesLatest
Dade Behring, Inc.22008-07-21
Beckman Instruments, Inc.21998-02-17
The Binding Site Group , Ltd.12014-04-16
The Binding Site, Ltd.11991-12-20
Kallestad Diag, A Div. of Erbamont, Inc.11989-12-01

6 more applicants have DEB clearances. See the full list in Caduvo.

Most recent DEB clearances

510(k)ApplicantDeviceDecision dateReview days
K140664The Binding Site Group , Ltd.HUMAN ALPHA2-MACROGLOBULIN KIT FOR USE ON SPAPLUS2014-04-1629
K081249Dade Behring, Inc.DIMENSION VISTA SYSTEM A2MAC FLEX REAGENT CARTRIDGE, DIMENSION VISTA SYSTEM PROTEIN 1 CALIBRATOR, DIMENSION VISTA SYSYEM2008-07-2180
K053073Dade Behring, Inc.N ANTISERA TO HUMAN ALPHA2-MACROGLOBULIN2006-03-28147
K974564Beckman Instruments, Inc.IMMAGE IMMUNOCHEMISTRY SYSTEM ALPHA-2-MACROGLOBULIN REAGENT1998-02-1774
K914389The Binding Site, Ltd.ALPHA-2 MACROGLOBULIN TEST RID KIT1991-12-2080

Recalls for DEB devices

openFDA lists no recalls for product code DEB.

Frequently asked questions

What is FDA product code DEB?

DEB is the FDA product code for alpha-2-macroglobulin, antigen, antiserum, control. It is a Class II device, regulated under 21 CFR 866.5620 and reviewed by the Immunology panel.

What device class is DEB?

Class II, regulation 21 CFR 866.5620. Typical premarket route: 510(k) exempt.

How long does a 510(k) take for product code DEB?

Across 13 cleared submissions the average was 66 days from receipt to decision (median 31).

Which companies have the most DEB clearances?

Dade Behring, Inc. (2); Beckman Instruments, Inc. (2); The Binding Site Group , Ltd. (1); The Binding Site, Ltd. (1); Kallestad Diag, A Div. of Erbamont, Inc. (1).

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All Immunology product codes · FDA product code lookup · 510(k) database search · 510(k) review times